PYC Therapeutics Statistics
Total Valuation
PYCXF has a market cap or net worth of 424.08 million. The enterprise value is 393.43 million.
| Market Cap | 424.08M |
| Enterprise Value | 393.43M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +25.01% |
| Shares Change (QoQ) | +13.87% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 315.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 27.42 |
| PB Ratio | 12.30 |
| P/TBV Ratio | 13.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.19 |
| EV / Sales | 24.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.83 |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.46 |
| Quick Ratio | 5.41 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -1,225.35 |
Financial Efficiency
Return on equity (ROE) is -112.79% and return on invested capital (ROIC) is -71.07%.
| Return on Equity (ROE) | -112.79% |
| Return on Assets (ROA) | -58.01% |
| Return on Invested Capital (ROIC) | -71.07% |
| Return on Capital Employed (ROCE) | -88.15% |
| Revenue Per Employee | 3.09M |
| Profits Per Employee | -5.97M |
| Employee Count | 5 |
| Asset Turnover | 0.46 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 23.92 |
| Average Volume (20 Days) | 3,320 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PYCXF had revenue of 15.46 million and -29.83 million in losses. Loss per share was -0.07.
| Revenue | 15.46M |
| Gross Profit | 15.46M |
| Operating Income | -31.01M |
| Pretax Income | -30.15M |
| Net Income | -29.83M |
| EBITDA | -30.58M |
| EBIT | -31.01M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 30.48 million in cash and 748,071 in debt, giving a net cash position of 29.73 million.
| Cash & Cash Equivalents | 30.48M |
| Total Debt | 748,071 |
| Net Cash | 29.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 34.47M |
| Book Value Per Share | 0.07 |
| Working Capital | 31.40M |
Cash Flow
In the last 12 months, operating cash flow was -30.18 million and capital expenditures -482,740, giving a free cash flow of -30.66 million.
| Operating Cash Flow | -30.18M |
| Capital Expenditures | -482,740 |
| Free Cash Flow | -30.66M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -200.55% and -192.90%.
| Gross Margin | 100.00% |
| Operating Margin | -200.55% |
| Pretax Margin | -194.96% |
| Profit Margin | -192.90% |
| EBITDA Margin | -197.75% |
| EBIT Margin | -200.55% |
| FCF Margin | n/a |
Dividends & Yields
PYCXF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.01% |
| Shareholder Yield | -25.01% |
| Earnings Yield | -7.03% |
| FCF Yield | -7.23% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PYCXF has an Altman Z-Score of 21.34.
| Altman Z-Score | 21.34 |
| Piotroski F-Score | n/a |